To include your compound in the COVID-19 Resource Center, submit it here.

Alexion announces makeover plans

On Sept. 12, Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) announced a restructuring plan aimed at streamlining costs while expanding its pipeline. The plan includes headcount reductions, facility closures, and the relocation of its headquarters to Boston, Mass. from New Haven, Conn.

Under the plan, Alexion will reduce global headcount by 600 (20%) over

Read the full 504 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers